Moomoo AI 已提取核心信息
Aditxt, Inc., a biotechnology company incorporated in Delaware, has successfully completed an exempt offering of securities, raising a total of $6,000,000 USD as reported in a new Form D notice filed with the U.S. Securities and Exchange Commission (SEC). The offering, which was not associated with a business combination transaction, included equity and securities to be acquired upon the exercise of options, warrants, or other rights. The date of the first sale was December 29, 2023, and the offering was completed without extending beyond one year. Aditxt has indicated that none of the proceeds will be used for payments to any of the executive officers, directors, or promoters listed in the filing. The company has declined to disclose its revenue range or...Show More
Aditxt, Inc., a biotechnology company incorporated in Delaware, has successfully completed an exempt offering of securities, raising a total of $6,000,000 USD as reported in a new Form D notice filed with the U.S. Securities and Exchange Commission (SEC). The offering, which was not associated with a business combination transaction, included equity and securities to be acquired upon the exercise of options, warrants, or other rights. The date of the first sale was December 29, 2023, and the offering was completed without extending beyond one year. Aditxt has indicated that none of the proceeds will be used for payments to any of the executive officers, directors, or promoters listed in the filing. The company has declined to disclose its revenue range or aggregate net asset value. The Form D filing also notes that H.C. Wainwright & Co., LLC was not compensated as a broker or dealer in connection with the offering. The total number of investors in the offering was one, and sales commissions totaled $495,000 USD. The company's executive team, including CEO Amro Albanna, CCO Corinne Pankovcin, COO Rowena Albanna, CIO Shahrokh Shabahang, CFO Thomas Farley, and directors Brian Brady, Jeffrey Runge, and Charles Nelson, are named in the filing. The notice was signed by CEO Amro Albanna on January 23, 2024.
Aditxt, Inc. 是一家在特拉华州注册的生物技术公司，已成功完成证券的豁免发行，根据向美国证券交易委员会（SEC）提交的新Form D通知中所述，共筹集了600万美元。此次发行与企业合并交易无关，包括在行使期权、认股权证或其他权利时收购的股票和证券。首次出售的日期是2023年12月29日，此次发行没有超过一年的时间就完成了。Aditxt表示，任何收益都不会用于向文件中列出的任何执行官、董事或发起人付款。该公司拒绝透露其收入范围或总净资产价值。D表文件还指出，H.C. Wainwright & Co., LLC没有获得与本次发行有关的经纪人或交易商的报酬。此次发行的投资者总数为一人，销售...展开全部
Aditxt, Inc. 是一家在特拉华州注册的生物技术公司，已成功完成证券的豁免发行，根据向美国证券交易委员会（SEC）提交的新Form D通知中所述，共筹集了600万美元。此次发行与企业合并交易无关，包括在行使期权、认股权证或其他权利时收购的股票和证券。首次出售的日期是2023年12月29日，此次发行没有超过一年的时间就完成了。Aditxt表示，任何收益都不会用于向文件中列出的任何执行官、董事或发起人付款。该公司拒绝透露其收入范围或总净资产价值。D表文件还指出，H.C. Wainwright & Co., LLC没有获得与本次发行有关的经纪人或交易商的报酬。此次发行的投资者总数为一人，销售佣金总额为49.5万美元。文件中列出了该公司的执行团队，包括首席执行官阿姆罗·阿尔班纳、首席运营官科琳娜·潘科夫辛、首席运营官罗文娜·阿尔班纳、首席信息官沙罗克·沙巴昂、首席财务官托马斯·法利以及董事布莱恩·布雷迪、杰弗里·朗格和查尔斯·纳尔逊。该通知由首席执行官阿姆罗·阿尔班纳于2024年1月23日签署。
有用
没用
